Giuseppe Malleo

Has grant

Associate Professor

Università degli Studi di Torino

Italy

Research Interests

Explore related searches

Professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Giuseppe Malleo is an Associate Professor at Università degli Studi di Verona, Italy. His research primarily focuses on pancreatic cancer, particularly outcomes following pancreatectomy, radiomics for operative risk assessment, and the implications of pathological staging for adjuvant therapy. He has contributed to various articles addressing recurrence predictors and the management of postoperative complications in patients with pancreatic ductal adenocarcinoma.

Recent Grants

Grant: Close

Clinical application of the research on pancreatic cancer genome

Open Date: 2014-05-01

Close Date: 2017-04-01

Articles (13)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (2)

Claudio Luchini

Associate Professor of Pathology

University of Verona

ITALY

View details

Alessandro Esposito

Professore a Contratto

University of Verona

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Giuseppe Malleo

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (13)

A dynamic analysis of empirical survival outcomes after pancreatectomy for pancreatic ductal adenocarcinoma

ASO Author Reflections: Recurrence Following Post-neoadjuvant Pancreatectomy: How Can We Do Better?

ASO Visual Abstract: Ca 19.9 Response and Tumor Size Predict Recurrence Following Post-neoadjuvant Pancreatectomy in Initially Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma

CA19.9 Response and Tumor Size Predict Recurrence Following Post-neoadjuvant Pancreatectomy in Initially Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma

Pathological staging in postneoadjuvant pancreatectomy for pancreatic cancer: implications for adjuvant therapy

Outcomes of a 3-Year Prospective Surveillance in Individuals at High Risk of Pancreatic Cancer

Radiomics preoperative-Fistula Risk Score (RAD-FRS) for pancreatoduodenectomy: development and external validation

Routine prophylactic abdominal drainage versus no-drain strategy after distal pancreatectomy: A multicenter propensity score matched analysis

ASO Author Reflection: Location of Nodal Metastases in Pancreatoduodenectomy for Cancer: Which Station Matters?

ASO Visual Abstract: Importance of Nodal Metastases Location in Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: Results from a Prospective Lymphadenectomy Protocol

Importance of Nodal Metastases Location in Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: Results from a Prospective, Lymphadenectomy Protocol

Long-term Outcomes After Surgical Resection of Pancreatic Metastases from Renal Clear-Cell Carcinoma

ASO Author Reflections: Long-Term Outcomes After Surgical Resection of Pancreatic Metastases from Renal Clear-Cell Carcinoma

Collaborators (2)

Claudio Luchini

Alessandro Esposito

Make your next move.